Literatura

Viza D, Fudenberg HH, Palareti A, Ablashi D, De Vinci C, Pizza G. Transfer factor: an overlooked potential for the prevention and treatment of infectious diseases. Folia Biol (Praha). 2013;59(2):53-67. Review.

Bartůňková J. Imunomodulační léčba. Forum medicinae 2001;3(5-6):124-128.

Barnet K, Hříbatová. V, Pekárek J. Čech K. The costimulatory activity of DLE-TF and PHA on thymocytes. In: Fujisawa T, et al, Eds, Recent advances in transfer factor and dialysable elukocyte extracts. Tokyo: Marusen Co, Ltd. 1991:80-86.

Barnet K. Co je a co není DLE-TF? Význam experimentu pro kliniku. Prakt Lék 1993;73:151-153.

Barnet K. Vacek A, Čech K, et al. The effect of DLE-fractions on GM-progenitors on haemopoetic stem cells in vitro. Biotherapy 1996;9:171-174.

Bukowski KM, Deodhar S, Hewlet JS. Imunotherapy of human neoplasma with transfer factor. In: Aschner MS, Gottlieb AA, Kirkpatrick CK, Eds.
Transfer factor. New York, Academic Press, 1976:543-551.

Bystroň J. Čech K, Pekárek J, Jílková J. Effect of anti-herpes specific transfer factor. Biotherapy 1996;9:73-77.

Fučíková. T, Marečková H, Hausner P, et al. Vliv jednorázová aplikace transfer factoru na buněčnou imunitu. Prakt Lék 1993;73:154-158.

Pekárek J. Čech K, Barnet K. The clinical use of specific transfer factor. In:

Fujisawa T, et al, Eds, Recent advances in transfer factor and dialysable leukocyte extracts. Tokyo: Marusen Co, Ltd, 1991:256-263.

Vrubel J, Hána I. Léčení buněčné imunodeficience u chirugických nemocných. Čes Slov Epidemiol Mikrobiol Imunol 1993;39:297-213.